首页|期刊导航|中华医学杂志(英文版)|Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
Jiaxiang Liu Qingyao Shang Jiaqi Liu Jie Wang Jingbo Zhang Guangyu Shan Bing Xu Yueping Liu Jianming Ying Xin Wang Xiang Wang Shuangtao Zhao Chenxuan Yang Li Ma Qixi Wu Xiangzhi Meng Bo Zheng Changyuan Guo Kexin Feng
中华医学杂志(英文版)2023,Vol.136Issue(2):184-193,10.
中华医学杂志(英文版)2023,Vol.136Issue(2):184-193,10.DOI:10.1097/CM9.0000000000002411
Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
摘要
关键词
Breast neoplasms/CKMT1B/OR11M1P/Predictive model/Prognosis/Risk score/SMR3BKey words
Breast neoplasms/CKMT1B/OR11M1P/Predictive model/Prognosis/Risk score/SMR3B引用本文复制引用
Jiaxiang Liu,Qingyao Shang,Jiaqi Liu,Jie Wang,Jingbo Zhang,Guangyu Shan,Bing Xu,Yueping Liu,Jianming Ying,Xin Wang,Xiang Wang,Shuangtao Zhao,Chenxuan Yang,Li Ma,Qixi Wu,Xiangzhi Meng,Bo Zheng,Changyuan Guo,Kexin Feng..Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients[J].中华医学杂志(英文版),2023,136(2):184-193,10.基金项目
The study was supported by the National Key Research and Development Program of China(2019YFE0110000),National Natural Science Foundation of China(82072097),CAMS Innovation Fund for Medical Science(CIFMS)(2020-I2M-C&T-B-069,2021-I2M-1-014),and Beijing Hope Run Special Fund of Cancer Foundation of China(LC2020A18). (2019YFE0110000)